Glaucoma Therapeutics Market Size and Growth 2031

The glaucoma therapeutics market size is projected to reach US$ 8.02 billion by 2031 from US$ 6.24 billion in 2022. The market is expected to register a CAGR of 3.2% in 2021–2031. The development of novel drug delivery methods and combination therapies is likely to remain a key trend in the glaucoma therapeutics market.

Glaucoma Therapeutics Market Analysis

Glaucoma is a group of eye disorders characterized by the gradual loss of nerve tissue that would eventually lead to vision loss if left untreated. Prostaglandin analogs are among the drugs that are highly effective in reducing eye pressure by promoting better drainage from the eye. The surging prevalence of glaucoma and increasing product launches are expected to favor the glaucoma therapeutics market growth.

Glaucoma Therapeutics Market Overview

The aging population worldwide has led to an increasing incidence of glaucoma, creating a significant opportunity for the glaucoma treatment market growth. The demand for innovative therapies and management strategies is rising due to the higher susceptibility of the aging demographic to the disease. Additionally, the importance of regular eye check-ups for early detection and management of glaucoma has increased patient engagement and demand for advanced treatments. As healthcare systems cater to the needs of an aging population, investments in glaucoma research, development, and access to care are expected to fuel market growth in the coming years.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Glaucoma Therapeutics Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Glaucoma Therapeutics Market Drivers and Opportunities

Mounting Glaucoma Disease to Favor Market

As per the Glaucoma Research Foundation, in 2022, ~ 80 million were affected with glaucoma globally. In 2010, nearly 8.4 million people worldwide had lost their vision due to primary open-angle glaucoma. According to the Glaucoma Research Foundation, the number is projected to increase to 22 million by 2040. This is expected to increase demand for treatments for glaucoma in the coming period. Propelling incidences of glaucoma among the global population are a major driver of the global glaucoma therapeutics market.

Development of Wearable Technologies – An Opportunity in Customization of Glaucoma Therapeutics

Glaucoma is a major cause of blindness, and early detection and treatment are vital. Wearable glaucoma diagnostics and therapeutics have emerged as potential solutions. Conventional diagnostic techniques provide reliable intraocular pressure data, but emerging contact lenses such as Sensimed Triggerfish offer continuous IOP tracking. For therapy, drug-eluting contact lenses are emerging as a potential solution. Theranostic platforms combine diagnostic and therapeutic capabilities into a single device to offer real-time monitoring and personalized medication dosing.

Glaucoma Therapeutics Market Report Segmentation Analysis

Key segments that contributed to the derivation of the glaucoma therapeutics market analysis are drug class, indication, and distribution channel.

• Based on drug class, the glaucoma therapeutics market is divided into beta blockers, alpha-adrenergic agonists, prostaglandins analogs, carbonic anhydrase inhibitors, combination drugs, and others. The prostaglandins analogs segment held the largest market share in 2023.
• The market is segmented by indication into open angle glaucoma, angle closure glaucoma, and others. The open-angle glaucoma segment held the largest share of the market in 2023.
• In terms of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominated the market in 2023. 

Glaucoma Therapeutics Market Share Analysis by Geography

The geographic scope of the glaucoma therapeutics Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

In 2022, nearly 2.7 million Americans were affected by open-angle glaucoma; glaucoma was the leading cause of irreversible blindness in the US. Due to rising incidences of glaucoma in the region, North America held the largest share in 2022. The growing proclivity toward novel combination therapies and minimally invasive glaucoma treatments and the presence of key market players in North America are factors contributing to the growth of the glaucoma therapeutics market in the region.

Glaucoma Therapeutics Market Regional Insights

The regional trends and factors influencing the Glaucoma Therapeutics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Glaucoma Therapeutics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Glaucoma Therapeutics Market Market Report Scope

Market Players Density: Understanding Its Impact on Business Dynamics

The Glaucoma Therapeutics Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Glaucoma Therapeutics Market are:

1. Alcon AG
2. AbbVie Inc
3. Bausch & Lomb Inc
4. Fera Pharmaceuticals, LLC
5. Viatris Inc
6. Novartis AG

Disclaimer: The companies listed above are not ranked in any particular order.

Glaucoma Therapeucs Market News and Recent Developments

The glaucoma therapeutics market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for glaucoma therapeutics:

• The US Food and Drug Administration (FDA) approved Glaukos Corporation’s New Drug Application (NDA) for a single administration per eye of iDose TR (travoprost intracameral implant) 75 mcg, a prostaglandin analog indicated for the reduction of intraocular pressure (IOP) in patients with ocular hypertension (OHT) or open-angle glaucoma (OAG). (Source: Glaukos Corporation, Company News, 2023)
• Alcon announced the acquisition of Aerie Pharmaceuticals, Inc. Through the transaction, the company acquired Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% and Rhopressa (netarsudil ophthalmic solution) 0.02%, along with AR-15512, a Phase 3 product candidate for dry eye disease, and a pipeline of several clinical and preclinical ophthalmic pharmaceutical product candidates. Rocklatan and Rhopressa are Rho-kinase inhibitors indicated for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension. The acquisition is expected to broaden Alcon’s portfolio across glaucoma, retina, and ocular surface disease. (Source: Alcon, Press Release, 2022)

GLAUCOMA THERAPEUTICS Market Report Coverage and Deliverables

The “Glaucoma Therapeutics Market Size and Forecast (2022–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles